AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3529043 — intervention group
Group type: COMPARATOR
Intervention: Scrubsuits removed before and put on again following lunch
Number of subjects: 0
Study 3529043 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatments affecting incidence of S. aureus contamination
Number of subjects: 0
Study 3529043 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing covergowns
Number of subjects: 0
Study 29237131 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% SDF applied annually
Number of subjects: 888
Study 29237131 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% SDF applied semiannually
Number of subjects: 888
Study 29237131 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% SDF applied annually
Number of subjects: 888
Study 29237131 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% SDF applied semiannually
Number of subjects: 888
Study 27347302 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% with 1µg/kg of clonidine
Number of subjects: 40
Study 27347302 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.5% with placebo
Number of subjects: 40
Study 24556040 — intervention group
Group type: EXPERIMENTAL
Intervention: Dovitinib (500 mg orally, 5 days on and 2 days off)
Number of subjects: 570
Study 24556040 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib (400 mg orally twice daily)
Number of subjects: 570
Study 24556040 — intervention group
Group type: EXPERIMENTAL
Intervention: Dovitinib
Number of subjects: 570
Study 24556040 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 570
Study 23174050 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% SIG1273 gel
Number of subjects: 30
Study 23174050 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 30
Study 20923901 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting interventions
Number of subjects: 0
Study 20923901 — intervention group
Group type: COMPARATOR
Intervention: Services as usual (control group)
Number of subjects: 0
Study 16430546 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (12 mg)
Number of subjects: 60
Study 16430546 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (12 mg) + Dexmedetomidine (3 microg)
Number of subjects: 60
Study 16430546 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (12 mg) + Clonidine (30 microg)
Number of subjects: 60
Study 11573379 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescreening for AAA at five-year intervals for men with initially ectatic aortas sized 25-29 mm
Number of subjects: 6339
Study 11573379 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation of small AAA
Number of subjects: 6339
Study 11573379 — intervention group
Group type: COMPARATOR
Intervention: Control group of men (380 men)
Number of subjects: 6339
Study 11573379 — intervention group
Group type: EXPERIMENTAL
Intervention: Men with a ratio > 1.2
Number of subjects: 6339
Study 9254267 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetothermia combined with chemotherapy using fluorouracil
Number of subjects: 11
Study 9254267 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with fluorouracil
Number of subjects: 11
Study 8494129 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% nitroglycerin
Number of subjects: 30
Study 8494129 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 30
Study 2892130 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime plus a long course (nine days) of amikacin
Number of subjects: 872
Study 2892130 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime plus a short course (three days) of amikacin
Number of subjects: 872
Study 2892130 — intervention group
Group type: EXPERIMENTAL
Intervention: Azlocillin plus a long course (nine days) of amikacin
Number of subjects: 872
Study 30606384 — intervention group
Group type: EXPERIMENTAL
Intervention: Attending the 'Red Ribbon in Colleges' event
Number of subjects: 1977
Study 30606384 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving AIDS prevention education as a freshman
Number of subjects: 1977
Study 30606384 — intervention group
Group type: EXPERIMENTAL
Intervention: Filling in AIDS prevention questionnaires
Number of subjects: 1977
Study 30606384 — intervention group
Group type: EXPERIMENTAL
Intervention: Attending other AIDS-related health education events in schools or colleges
Number of subjects: 1977
Study 30606384 — intervention group
Group type: COMPARATOR
Intervention: Not attending any of these events
Number of subjects: 1977
Study 30606384 — intervention group
Group type: EXPERIMENTAL
Intervention: Majoring in engineering disciplines
Number of subjects: 1977
Study 30606384 — intervention group
Group type: EXPERIMENTAL
Intervention: Being a junior student
Number of subjects: 1977
Study 30606384 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in central China
Number of subjects: 1977
Study 30606384 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in northern China
Number of subjects: 1977
Study 26643687 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program (G-I, n = 137)
Number of subjects: 256
Study 26643687 — intervention group
Group type: COMPARATOR
Intervention: Control group (G-II, n = 119)
Number of subjects: 256
Study 26643687 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups underwent the educational program at T-12
Number of subjects: 256
Study 24952836 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping with skin convolutions (10 to 15% tension applied in flexion)
Number of subjects: 148
Study 24952836 — intervention group
Group type: COMPARATOR
Intervention: Kinesio Taping with no tension (sham taping)
Number of subjects: 148
Study 24952836 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping with skin convolutions
Number of subjects: 148
Study 22969230 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite yogurt enriched with acacia dietary fiber and Bifidobacterium lactis (B. lactis), consumed twice daily for 8 weeks
Number of subjects: 130
Study 20356870 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilator therapy
Number of subjects: 7599
Study 20356870 — intervention group
Group type: COMPARATOR
Intervention: Candesartan
Number of subjects: 7599
Study 20356870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7599
Study 19027263 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg bolus followed by 0.25 mg/kg per hour continuous infusion)
Number of subjects: 36
Study 19027263 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.5 mg/kg bolus followed by 0.25 mg/kg per hour continuous infusion)
Number of subjects: 36
Study 16122472 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients after arch repair
Number of subjects: 20
Study 16122472 — intervention group
Group type: COMPARATOR
Intervention: Age-matched control subjects
Number of subjects: 20
Study 12735675 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 50 microg b.d. plus FP250 (SM/FP250)
Number of subjects: 496
Study 12735675 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate 250 microg b.d. (FP250)
Number of subjects: 496
Study 12735675 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate 500 microg b.d. (FP500)
Number of subjects: 496
Study 11158748 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal artesunate (10 mg/kg)
Number of subjects: 34
Study 11158748 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal artesunate (20 mg/kg)
Number of subjects: 34
Study 11158748 — intervention group
Group type: COMPARATOR
Intervention: Intravenous artesunate (2.4 mg/kg)
Number of subjects: 34
Study 11158748 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 34
Study 9266868 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol every 30 min (group 1, n=34)
Number of subjects: 100
Study 9266868 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol every 60 min (group 2, n=33)
Number of subjects: 100
Study 9266868 — intervention group
Group type: COMPARATOR
Intervention: Albuterol every 120 min (group 3, n=33)
Number of subjects: 100
Study 9266868 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol treatment for low responders (<15 percentage point increase at 15 min)
Number of subjects: 100
Study 9266868 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol treatment for high responders (>15 percentage point increase at 15 min)
Number of subjects: 100
Study 9266868 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium levels
Number of subjects: 100
Study 9266868 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events and hospitalization rates
Number of subjects: 100
Study 8499939 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid meal feeding (MW)
Number of subjects: 10
Study 8499939 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid meal feeding (M)
Number of subjects: 10
Study 8499939 — intervention group
Group type: COMPARATOR
Intervention: Control (W)
Number of subjects: 10
Study 3810772 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy (high normal hemoglobin concentration, 15 g/l or more)
Number of subjects: 1377
Study 3810772 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy (lower hemoglobin concentration, less than 15 g/l)
Number of subjects: 1377
Study 3810772 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical therapy (extracranial‐intracranial bypass)
Number of subjects: 1377
Study 30138152 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity educational intervention (n = 100)
Number of subjects: 201
Study 30138152 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity educational intervention (n = 101)
Number of subjects: 201
Study 30138152 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity educational intervention
Number of subjects: 201
Study 30138152 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sampling
Number of subjects: 201
Study 27687417 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate 20 mg/kg in bolus followed by magnesium 2 mg kg(‐1) h(‐1) (group M)
Number of subjects: 60
Study 27687417 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac 30 mg in bolus followed by saline infusion (group K)
Number of subjects: 60
Study 27687417 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline solution 20 mL in bolus followed by saline infusion during the entire procedure (group S)
Number of subjects: 60
Study 25626413 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calcium milk powder supplementation (50g containing 450mg elemental calcium and 400IU vitamin D, taken every morning and evening)
Number of subjects: 141
Study 25626413 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calcium milk powder supplementation
Number of subjects: 141
Study 25626413 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 141
Study 24320907 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine dietary supplement (3g)
Number of subjects: 117
Study 24320907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 21403011 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion slow-release (SR)
Number of subjects: 151
Study 21403011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 18600319 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F‐FDG PET
Number of subjects: 160
Study 18600319 — intervention group
Group type: COMPARATOR
Intervention: MDCT
Number of subjects: 160
Study 18600319 — intervention group
Group type: EXPERIMENTAL
Intervention: Side‐by‐side visual correlation of MDCT and (18)F‐FDG PET
Number of subjects: 160
Study 18600319 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F‐FDG PET and extended‐field MDCT
Number of subjects: 160
Study 17194262 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 80
Study 17194262 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 80
Study 12727949 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg continuous estradiol with 10 mg medroxyprogesterone acetate
Number of subjects: 28
Study 12727949 — intervention group
Group type: COMPARATOR
Intervention: 2 mg continuous estradiol with 10 mg medroxyprogesterone acetate
Number of subjects: 28
Study 10802791 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life in Epilepsy (QOLIE)-89
Number of subjects: 0
Study 10802791 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life in Epilepsy (QOLIE)-31
Number of subjects: 0
Study 10802791 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Form (SF)-36, IRT scoring
Number of subjects: 0
Study 10802791 — intervention group
Group type: COMPARATOR
Intervention: Short Form (SF)-36, classic test theory scoring
Number of subjects: 0
Study 10802791 — intervention group
Group type: COMPARATOR
Intervention: Short Form (SF)-12
Number of subjects: 0
Study 8751806 — intervention group
Group type: COMPARATOR
Intervention: Granisetron alone
Number of subjects: 12
Study 8751806 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron plus methylprednisolone (MPL)
Number of subjects: 12
Study 1478583 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer of the posterior tibialis tendon (N = 9)
Number of subjects: 15
Study 1478583 — intervention group
Group type: COMPARATOR
Intervention: Lengthening of the posterior tibialis tendon (N = 6)
Number of subjects: 15
Study 6397328 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone oenanthate (NET OEN) 200 mg injection every 60 +/‐ 5 days
Number of subjects: 2388
Study 6397328 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone oenanthate (NET OEN) 200 mg injection every 90 +/‐ 5 days
Number of subjects: 2388
Study 6397328 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone oenanthate (NET OEN) 200 mg injection
Number of subjects: 2388
Study 31196166 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic distal pancreatectomy (LDP)
Number of subjects: 60
Study 31196166 — intervention group
Group type: COMPARATOR
Intervention: Open distal pancreatectomy (ODP)
Number of subjects: 60
Study 28733270 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based coaching program using EHRs
Number of subjects: 130
Study 28733270 — intervention group
Group type: COMPARATOR
Intervention: Routine care with the addition of the Web-based coaching program using EHRs
Number of subjects: 130
Study 28733270 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 130
Study 25753514 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B
Number of subjects: 25
Study 25753514 — intervention group
Group type: COMPARATOR
Intervention: Control side received laser treatment plus phototherapy
Number of subjects: 25
Study 23450386 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosis risk label with accurate information
Number of subjects: 153
Study 23450386 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosis risk label without accurate information
Number of subjects: 153
Study 23450386 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia label
Number of subjects: 153
Study 23450386 — intervention group
Group type: COMPARATOR
Intervention: Nonpsychotic disorders (major depression, generalized anxiety disorder)
Number of subjects: 153
Study 22093477 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAsp 30
Number of subjects: 52
Study 22093477 — intervention group
Group type: COMPARATOR
Intervention: BHI 30
Number of subjects: 52
Study 19744725 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN)‐alfa‐2a treatment (3 MIU subcutaneously 3 times per week for 2 years)
Number of subjects: 121
Study 19744725 — intervention group
Group type: COMPARATOR
Intervention: Control group (radiation or enucleation only)
Number of subjects: 121
Study 19744725 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN)‐alfa‐2a treatment
Number of subjects: 121
Study 16420531 — intervention group
Group type: EXPERIMENTAL
Intervention: Malignant melanomas
Number of subjects: 60
Study 16420531 — intervention group
Group type: EXPERIMENTAL
Intervention: Melanocytic nevi
Number of subjects: 60
Study 16420531 — intervention group
Group type: COMPARATOR
Intervention: Control (non-lesional skin)
Number of subjects: 60
Study 14765870 — intervention group
Group type: COMPARATOR
Intervention: Dermatomal quantitative sensory tests
Number of subjects: 27
Study 14765870 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompressive surgery
Number of subjects: 27
Study 14765870 — intervention group
Group type: COMPARATOR
Intervention: Low back pain assessment
Number of subjects: 27
Study 11734652 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen ablative therapy
Number of subjects: 0
Study 9148705 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural spinal cord stimulation (ESCS)
Number of subjects: 237
Study 7584279 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger subjects
Number of subjects: 12
Study 7584279 — intervention group
Group type: EXPERIMENTAL
Intervention: Older subjects
Number of subjects: 12
Study 7584279 — intervention group
Group type: EXPERIMENTAL
Intervention: Older-old subjects (> or = 70 years old)
Number of subjects: 12
Study 7584279 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of certain mnemonic strategies
Number of subjects: 12
Study 3631181 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (n = 14)
Number of subjects: 26
Study 3631181 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 12)
Number of subjects: 26
Study 30785868 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-high intensity aerobic exercise training (AET)
Number of subjects: 0
Study 30785868 — intervention group
Group type: COMPARATOR
Intervention: Stretching/toning (ST) control intervention
Number of subjects: 0
Study 30785868 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (combined AET and ST)
Number of subjects: 0
Study 28446523 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week online parenting programme
Number of subjects: 0
Study 28446523 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study 25997425 — intervention group
Group type: EXPERIMENTAL
Intervention: High serum NT-proBNP level on hospital admission (≥ 2,563.6 pg/ml)
Number of subjects: 218
Study 25997425 — intervention group
Group type: COMPARATOR
Intervention: Non-ST-segment resolution (non-STR) group
Number of subjects: 218
Study 25997425 — intervention group
Group type: COMPARATOR
Intervention: ST-segment resolution (STR) group
Number of subjects: 218
Study 23538435 — intervention group
Group type: EXPERIMENTAL
Intervention: galyfilcon A/polyhexanide (combination 1)
Number of subjects: 37
Study 23538435 — intervention group
Group type: COMPARATOR
Intervention: balafilcon A/polyquaternium‐1 and myristamidopropyl dimethylamine + TearGlyde (combination 2)
Number of subjects: 37
Study 21615886 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg
Number of subjects: 404
Study 21615886 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 300 μg
Number of subjects: 404
Study 21615886 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 600 μg
Number of subjects: 404
Study 21615886 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo/moxifloxacin
Number of subjects: 404
Study 21615886 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 404
Study 19384215 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonobstructive 'quiet' family witness
Number of subjects: 30
Study 19384215 — intervention group
Group type: EXPERIMENTAL
Intervention: Family witness displaying an overt grief reaction
Number of subjects: 30
Study 19384215 — intervention group
Group type: COMPARATOR
Intervention: No family witness
Number of subjects: 30
Study 16699308 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine restricted group
Number of subjects: 81
Study 16699308 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81
Study 15231461 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (5 mg)
Number of subjects: 111
Study 15231461 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (5 mg)
Number of subjects: 111
Study 15231461 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam (2 mg)
Number of subjects: 111
Study 12472345 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% hydroquinone cream combined with glycolic acid peels
Number of subjects: 21
Study 12472345 — intervention group
Group type: COMPARATOR
Intervention: 4% hydroquinone cream
Number of subjects: 21
Study 9799140 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally extraperitoneal endoscopic hernia operation (TEP)
Number of subjects: 45
Study 9799140 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein mesh repair (OPN)
Number of subjects: 45
Study 7618930 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulphamethoxazole (TMP-SMX)
Number of subjects: 55
Study 7618930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 2793706 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 10
Study 2793706 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 10
Study 335795 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 9
Study 335795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31880749 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 104
Study 31880749 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure (VRE)
Number of subjects: 104
Study 31880749 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 104
Study 30958285 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (3 sessions, once every 4-5 days)
Number of subjects: 29
Study 30958285 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined extracorporeal shock wave therapy (3 sessions, once every 4-5 days) and local use of silicone gel Strataderm
Number of subjects: 29
Study 30958285 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preventive measures)
Number of subjects: 29
Study 28304227 — intervention group
Group type: EXPERIMENTAL
Intervention: Bococizumab 150 mg subcutaneously every 2 weeks
Number of subjects: 4300
Study 28304227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4300